{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:18:59Z","timestamp":1758759539576,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,24]]},"DOI":"10.7759\/cureus.93127","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:05Z","timestamp":1758733385000},"source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis Coinciding With Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma: A Diagnostic Conundrum"],"prefix":"10.7759","author":[{"given":"Nithiyanandan","family":"Ravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning HJ","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, et al.. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020, 382:503-13. 10.1056\/NEJMoa1911793","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.798465","article-title":"Epidemic trends in high tuberculosis burden countries during the last three decades and feasibility of achieving the global targets at the country level","volume":"9","author":"Ding C","year":"2022","unstructured":"Ding C, Hu M, Shangguan Y, et al.. Epidemic trends in high tuberculosis burden countries during the last three decades and feasibility of achieving the global targets at the country level. Front Med (Lausanne). 2022, 9:798465. 10.3389\/fmed.2022.798465","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2025.100522","article-title":"Strengthening the global response to tuberculosis: insights from the 2024 WHO global TB report","volume":"39","author":"Estaji F","year":"2025","unstructured":"Estaji F, Kamali A, Keikha M. Strengthening the global response to tuberculosis: insights from the 2024 WHO global TB report. J Clin Tuberc Other Mycobact Dis. 2025, 39:100522. 10.1016\/j.jctube.2025.100522","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12587","article-title":"The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"7","author":"Zhang YL","year":"2016","unstructured":"Zhang YL, Yuan JQ, Wang KF, et al.. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016, 7:78985-93. 10.18632\/oncotarget.12587","journal-title":"Oncotarget"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2017.07.012","article-title":"Overall survival analysis and characterization of an EGFR mutated non-small cell lung cancer (NSCLC) population","volume":"54","author":"Aguiar F","year":"2018","unstructured":"Aguiar F, Fernandes G, Queiroga H, Machado JC, Cirnes L, Souto Moura C, Hespanhol V. Overall survival analysis and characterization of an EGFR mutated non-small cell lung cancer (NSCLC) population. Arch Bronconeumol (Engl Ed). 2018, 54:10-7. 10.1016\/j.arbres.2017.07.012","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v3i2.135","article-title":"Coexistence of pulmonary tuberculosis and small cell lung carcinoma: a significant problem in tuberculosis-endemic country?","volume":"3","author":"Arliny Y","year":"2023","unstructured":"Arliny Y, Yanifitri DB, Purqan M, Fachri M. Coexistence of pulmonary tuberculosis and small cell lung carcinoma: a significant problem in tuberculosis-endemic country?. Narra J. 2023, 3:e135. 10.52225\/narra.v3i2.135","journal-title":"Narra J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.084","article-title":"Impact of pulmonary tuberculosis on the EGFR mutational status and clinical outcome in patients with lung adenocarcinoma","volume":"51","author":"Hwang IK","year":"2019","unstructured":"Hwang IK, Paik SS, Lee SH. Impact of pulmonary tuberculosis on the EGFR mutational status and clinical outcome in patients with lung adenocarcinoma. Cancer Res Treat. 2019, 51:158-68. 10.4143\/crt.2018.084","journal-title":"Cancer Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2024.100729","article-title":"The burden of tuberculosis among patients with non-small cell lung carcinoma in a tertiary care center","volume":"52","author":"Mahishi N","year":"2024","unstructured":"Mahishi N, Bala K, Malik P, et al.. The burden of tuberculosis among patients with non-small cell lung carcinoma in a tertiary care center. Indian J Med Microbiol. 2024, 52:100729. 10.1016\/j.ijmmb.2024.100729","journal-title":"Indian J Med Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2015.06.007","article-title":"Tuberculosis mimicking lung cancer","volume":"16","author":"Hammen I","year":"2015","unstructured":"Hammen I. Tuberculosis mimicking lung cancer. Respir Med Case Rep. 2015, 16:45-7. 10.1016\/j.rmcr.2015.06.007","journal-title":"Respir Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.62889","article-title":"Navigating diagnostic pitfalls: false positivity in GeneXpert Mycobacterium tuberculosis\/rifampicin assay","volume":"16","author":"Bagrecha M","year":"2024","unstructured":"Bagrecha M, Ganta SV, Mirza S. Navigating diagnostic pitfalls: false positivity in GeneXpert Mycobacterium tuberculosis\/rifampicin assay. Cureus. 2024, 16:e62889. 10.7759\/cureus.62889","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00065-2019","article-title":"Comparison between the diagnostic accuracy of Xpert MTB\/Rif assay and culture for pleural tuberculosis using tissue biopsy","volume":"5","author":"Akhter N","year":"2019","unstructured":"Akhter N, Sumalani KK, Chawla D, Ahmed Rizvi N. Comparison between the diagnostic accuracy of Xpert MTB\/Rif assay and culture for pleural tuberculosis using tissue biopsy. ERJ Open Res. 2019, 5:00065-2019. 10.1183\/23120541.00065-2019","journal-title":"ERJ Open Res"},{"key":"ref12","article-title":"Rapid diagnosis of pleural tuberculosis by Xpert MTB\/RIF assay using pleural biopsy and pleural fluid specimens","volume":"20","author":"Du J","year":"2015","unstructured":"Du J, Huang Z, Luo Q, et al.. Rapid diagnosis of pleural tuberculosis by Xpert MTB\/RIF assay using pleural biopsy and pleural fluid specimens. J Res Med Sci. 2015, 20:26-31.","journal-title":"J Res Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.644150","article-title":"Cancer or tuberculosis: a comprehensive review of the clinical and imaging features in diagnosis of the confusing mass","volume":"11","author":"Xiang Y","year":"2021","unstructured":"Xiang Y, Huang C, He Y, Zhang Q. Cancer or tuberculosis: a comprehensive review of the clinical and imaging features in diagnosis of the confusing mass. Front Oncol. 2021, 11:644150. 10.3389\/fonc.2021.644150","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.07.11","article-title":"Identifying lung cancer in patients with active pulmonary tuberculosis","volume":"10","author":"Parker CS","year":"2018","unstructured":"Parker CS, Siracuse CG, Litle VR. Identifying lung cancer in patients with active pulmonary tuberculosis. J Thorac Dis. 2018, 10:S3392-7. 10.21037\/jtd.2018.07.11","journal-title":"J Thorac Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10128-9","article-title":"New progress of tuberculosis scar carcinoma","volume":"42","author":"Sun W","year":"2023","unstructured":"Sun W, Liu Y, Zhao L, et al.. New progress of tuberculosis scar carcinoma. Cancer Metastasis Rev. 2023, 42:653-9. 10.1007\/s10555-023-10128-9","journal-title":"Cancer Metastasis Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2015.05.015","article-title":"Reactivation of pulmonary tuberculosis during cancer treatment","volume":"4","author":"Jacobs RE","year":"2015","unstructured":"Jacobs RE, Gu P, Chachoua A. Reactivation of pulmonary tuberculosis during cancer treatment. Int J Mycobacteriol. 2015, 4:337-40. 10.1016\/j.ijmyco.2015.05.015","journal-title":"Int J Mycobacteriol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/030089160208800313","article-title":"Reactivation of pulmonary tuberculosis in malignancy","volume":"88","author":"Karnak D","year":"2002","unstructured":"Karnak D, Kayacan O, Beder S. Reactivation of pulmonary tuberculosis in malignancy. Tumori. 2002, 88:251-4. 10.1177\/030089160208800313","journal-title":"Tumori"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017378","article-title":"Coexistence of lung adenocarcinoma and pulmonary tuberculosis within a single lesion: a rare case report","volume":"98","author":"Byun HG","year":"2019","unstructured":"Byun HG, Yoo JY, Kim SJ, Lee OJ, Yoo MY. Coexistence of lung adenocarcinoma and pulmonary tuberculosis within a single lesion: a rare case report. Medicine (Baltimore). 2019, 98:e17378. 10.1097\/MD.0000000000017378","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-008196","article-title":"Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsy","volume":"2013","author":"Madan K","year":"2013","unstructured":"Madan K, Singh N, Das A, Behera D. Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsy. BMJ Case Rep. 2013, 2013:bcr2012008196. 10.1136\/bcr-2012-008196","journal-title":"BMJ Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_503_16","article-title":"Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib\/erlotinib","volume":"54","author":"Gothi D","year":"2017","unstructured":"Gothi D, Spalgais S. Tuberculosis in epidermal growth factor receptor mutation in lung adenocarcinoma on treatment with gefitinib\/erlotinib. Indian J Cancer. 2017, 54:1. 10.4103\/ijc.IJC_503_16","journal-title":"Indian J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330152-tuberculosis-coinciding-with-epidermal-growth-factor-receptor-egfr-mutant-lung-adenocarcinoma-a-diagnostic-conundrum","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:05Z","timestamp":1758733385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330152-tuberculosis-coinciding-with-epidermal-growth-factor-receptor-egfr-mutant-lung-adenocarcinoma-a-diagnostic-conundrum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.93127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}